[The place of pyrogen therapy in the modern treatment of schizophrenia patients].
The author analyses experience gained with the use of the pyrogenic drugs sulfazin and pyrogenal in the treatment of schizophrenic patients. Pyrogenal and sulfazin were administered to 26 patients with different forms of schizophrenia to overcome psychopharmacotherapeutic resistance and to 11 patients to enhance the sensitivity to insulin during insulin coma therapy. Based on the clinical analysis the author demonstrates the efficacy of the use of the pyrogenic drugs, particularly pyrogenal, in schizophrenic patients in order to overcome the resistance to pharmacotherapy and insulin.
Malin
D I
DI
D003295:Convulsive Therapy; D004341:Drug Evaluation; D004351:Drug Resistance; D006801:Humans; D007333:Insulin Resistance; D011599:Psychopathology; D011619:Psychotropic Drugs / Q000037:antagonists & inhibitors; D011749:Pyrogens / Q000008:administration & dosage*; D012074:Remission Induction; D012559:Schizophrenia / Q000188:drug therapy*; D012560:Schizophrenia, Catatonic / Q000188:drug therapy; D012562:Schizophrenia, Disorganized / Q000188:drug therapy; D012563:Schizophrenia, Paranoid / Q000188:drug therapy
D011619:Psychotropic Drugs; D011749:Pyrogens
O meste pirogennoĭ terapii v sovremennom lechenii bol'nykh shizofrenieĭ.